The use of CAF by athletes' is mainly driven by its reported ability to improve exercise performance, and is therefore commonly used by endurance athletes in competitions since its removal from the World Anti-Doping Agency list in 2004. However, the specific mechanism explaining its ergogenic effects, and its effect on top trained endurance athletes is lacking scientific research.
NIH, aud A
The committee members:
Professor Olivier Seynnes, Norwegian School of Sport Sciences, chairperson
Professor Louise Burke, Australian Institute of Sports Nutrition
Associate professor Nikolai Baastrup Nordsborg, Department of Exercise and Sport Sciences, University of Copenhagen
10.15 – 11.00 Trial lecture on a given topic
13.00 – 16.00 Public defense followed by a discussion